Using new technology effectively can boost productivity and reinforce the value of diverse hiring practices.
Immix Biopharma reported successful dosing of six patients in its Phase 1b trial for the CAR-T therapy NXC-201. The press release acknowledges that no drugs are currently FDA approved for patients ...
A study has developed a reliable way to measure whether seriously ill hospitalized patients receive medical care that aligns with their personal goals. The research, involving 109 seriously ill ...
Glucotrack, Inc. has announced the successful completion of its first human clinical study for a continuous blood glucose monitor (CBGM), which is uniquely placed in the subclavian vein for real-time ...
New cancer research pioneered by Memorial Sloan Kettering points to a strong alternative to chemotherapy, surgery, and radiation for some forms of cancer. Nearly 80% of patients who suffered from a ...
Our Debt Free Family on MSN
Transform your study habits: 10 techniques for effective learning
Boost your learning with science-backed study techniques proven to improve focus, retention, and performance. These practical strategies help students of all ages study smarter, stay organized, and ...
Want to have successful IVF? If you're an older woman, find some donor eggs. Most successful fertility treatments for women 43 and older rely on donor eggs, researchers report in the journal ...
n = number of patients included in each study group for HbA1c and body weight efficacy assessments Abbreviations: EOS: End of Study (week 16); Wk: week; BID: twice daily; CBD: cannabidiol; QD: once ...
The sample for the current study was restricted to the 40% of participants who were deemed to be successfully aging at the start of the study. Previous studies have shown that marriage is associated ...
A study reveals that stable, moderate sleep patterns are linked to better health in older adults, while inconsistent or short sleep trajectories pose risks to physical, cognitive, and social ...
Stallergenes Greer, a global leader in allergy therapeutics, announced today that its Phase IIIb clinical study (YOBI, YOung patients and BIrch allergy), designed to confirm the safety and efficacy of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results